Cargando…

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma

Purpose: To identify the independent risk factors for transarterial embolization (TACE) refractoriness and to develop a novel TACE refractoriness score and nomogram for predicting TACE refractoriness in patients with hepatocellular carcinoma (HCC). Methods: Between March 2006 and March 2016, HCC pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Li, Yu, Chen-Xi, Zhong, Bin-Yan, Zhu, Hai-Dong, Jin, Zhi-Cheng, Zhu, Guang-Yu, Zhang, Qi, Ni, Cai-Fang, Teng, Gao-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109267/ https://www.ncbi.nlm.nih.gov/pubmed/33981722 http://dx.doi.org/10.3389/fmolb.2021.615133

Ejemplares similares

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
por: Zheng, Liyun, et al.
Publicado: (2021)

Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
por: Zhong, Bin-Yan, et al.
Publicado: (2021)

Development and Validation of a Predictive Model for Early Refractoriness of Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Wang, Tian-Cheng, et al.
Publicado: (2021)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2021)

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib
por: Zhang, Lei, et al.
Publicado: (2021)

Increased Potency of a Bi-specific TL1A-ADAM17 (TACE) Inhibitor by Cell Surface Targeting
por: Weizman, Tomer, et al.
Publicado: (2017)

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2022)

Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis
por: Gao, Qiannan, et al.
Publicado: (2022)

Advances of multi-omics applications in hepatic precancerous lesions and hepatocellular carcinoma: The role of extracellular vesicles
por: Lu, Xiaona, et al.
Publicado: (2023)

Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma
por: Bian, Saiyan, et al.
Publicado: (2020)

Hepatocyte-Specific Knock-Out of Nfib Aggravates Hepatocellular Tumorigenesis via Enhancing Urea Cycle
por: Zhou, Li, et al.
Publicado: (2022)

A Toolbox for Site-Specific Labeling of RecQ Helicase With a Single Fluorophore Used in the Single-Molecule Assay
por: Teng, Fang-Yuan, et al.
Publicado: (2020)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Implications of Lifestyle Factors and Polygenic Risk Score for Absolute Risk Prediction of Colorectal Neoplasm and Risk-Adapted Screening
por: Chen, Hongda, et al.
Publicado: (2021)

Case Report: One-Year Delay in the Effect of Conversion Surgery Therapy for Advanced Hepatocellular Carcinoma After Systemic Therapy
por: Xie, Qing-Yu, et al.
Publicado: (2022)

Classification of Hepatocellular Carcinoma Based on N6-Methylandenosine–Related lncRNAs Profiling
por: Yin, Lu, et al.
Publicado: (2022)

Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma
por: Liang, Yimin, et al.
Publicado: (2022)

High Expression of Long Non-Coding RNA TMCO1-AS1 is Associated With Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Xuelian, et al.
Publicado: (2022)

Genome-Wide Enhancer Analysis Reveals the Role of AP-1 Transcription Factor in Head and Neck Squamous Cell Carcinoma
por: Wang, Chen-Yu, et al.
Publicado: (2021)

A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
por: Fang, Shiji, et al.
Publicado: (2021)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Transarterial Chemoembolization (TACE) Combined with Sorafenib versus TACE Alone for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Study
por: Ren, Baosheng, et al.
Publicado: (2019)

An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma
por: Liu, Long, et al.
Publicado: (2021)

Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages
por: Chen, Qi, et al.
Publicado: (2021)

Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma
por: Deng, Xiaoyu, et al.
Publicado: (2021)

Development of a Toll-Like Receptor-Based Gene Signature That Can Predict Prognosis, Tumor Microenvironment, and Chemotherapy Response for Hepatocellular Carcinoma
por: Liu, Lixia, et al.
Publicado: (2021)

Theoretical Exploring Selective-Binding Mechanisms of JAK3 by 3D-QSAR, Molecular Dynamics Simulation and Free Energy Calculation
por: Zhu, Jingyu, et al.
Publicado: (2020)

A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry
por: Yang, Jiayue, et al.
Publicado: (2021)

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
por: Huang, Wu-Kui, et al.
Publicado: (2017)

Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma
por: Zhang, Shiyu, et al.
Publicado: (2023)

Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts
por: Wang, Hufei, et al.
Publicado: (2022)

Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma
por: Wen, Kai, et al.
Publicado: (2021)

Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Ma, Jiaxiu, et al.
Publicado: (2022)

ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
por: Chen, Weiqian, et al.
Publicado: (2020)

CXCR2 May Serve as a Useful Index of Disease Activity in Interstitial Lung Disease Associated With Primary Sjögren’s Syndrome
por: Zhu, Xiaofang, et al.
Publicado: (2021)

Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8(+) T Cell Infiltration
por: Zou, Yiping, et al.
Publicado: (2021)

Identifying Dendritic Cell–Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis
por: Huang, Chaoyuan, et al.
Publicado: (2021)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

LTF induces senescence and degeneration in the meniscus via the NF-κB signaling pathway: A study based on integrated bioinformatics analysis and experimental validation
por: Zhang, Jun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_53un2lqlsrbt2nj42vifhbppuj